Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis.
Pegiviruses frequently cause persistent infection (as defined by >6 months), but unlike most other Flaviviridae members, no apparent clinical disease. Human pegivirus (HPgV, previously GBV-C) is detectable in 1-4% of healthy individuals and another 5-13% are seropositive. Some evidence for infect...
Main Authors: | Joy E Tomlinson, Raphael Wolfisberg, Ulrik Fahnøe, Himanshu Sharma, Randall W Renshaw, Louise Nielsen, Eiko Nishiuchi, Christina Holm, Edward Dubovi, Brad R Rosenberg, Bud C Tennant, Jens Bukh, Amit Kapoor, Thomas J Divers, Charles M Rice, Gerlinde R Van de Walle, Troels K H Scheel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-07-01
|
Series: | PLoS Pathogens |
Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1008677&type=printable |
Similar Items
-
Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients
by: Ulrik Fahnøe, et al.
Published: (2024-09-01) -
Tropism, pathology, and transmission of equine parvovirus-hepatitis
by: Joy Ellen Tomlinson, et al.
Published: (2020-01-01) -
Nasal transmission of equine parvovirus hepatitis
by: Joy E. Tomlinson, et al.
Published: (2022-11-01) -
Etymologia: Pegivirus
by: Ronnie Henry
Published: (2020-02-01) -
Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014‐2018)
by: Joy E. Tomlinson, et al.
Published: (2019-01-01)